The eye clinic says most people on GLP-1 medicines don't need extra eye checks, but advises staying alert to any shift in eyesight.
Recap by typeshit. Post by @moorfields_private on Instagram.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Online sellers pitch peptides for weight loss, anti-aging and muscle gain, and Gavin Coote's full story looks at the risks of products nobody regulates.
A surgeon on social media says the FDA has received two death reports involving black-market retatrutide. No official FDA statement is linked.
Young users describe buying retatrutide, GHK-Cu and BPC-157 online, while doctors say the evidence behind many claims is weak.
New research points to a possible link between GLP-1 drugs and slower biological aging, as covered by the Texas station.
Loading…